Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo (Q33240972)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo |
scientific article |
Statements
1 reference
Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo (English)
1 reference
Marini P
1 reference
Denzinger S
1 reference
Schiller D
1 reference
Kauder S
1 reference
Welz S
1 reference
Humphreys R
1 reference
Daniel PT
1 reference
Jendrossek V
1 reference
Budach W
1 reference
Belka C
1 reference
24 April 2006
1 reference
1 reference
25
1 reference
37
1 reference
5145-5154
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference